Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

Perceived treatment, feedback, and placebo effects in double-blind RCTs: an experimental analysis.

Colagiuri B, Boakes RA.

Psychopharmacology (Berl). 2010 Feb;208(3):433-41. doi: 10.1007/s00213-009-1743-9. Epub 2009 Dec 9.

PMID:
19997906
2.

Participant expectancies in double-blind randomized placebo-controlled trials: potential limitations to trial validity.

Colagiuri B.

Clin Trials. 2010 Jun;7(3):246-55. doi: 10.1177/1740774510367916. Epub 2010 Apr 26. Review.

PMID:
20421243
3.

Lay public's understanding of equipoise and randomisation in randomised controlled trials.

Robinson EJ, Kerr CE, Stevens AJ, Lilford RJ, Braunholtz DA, Edwards SJ, Beck SR, Rowley MG.

Health Technol Assess. 2005 Mar;9(8):1-192, iii-iv.

4.

Changes in beliefs identify unblinding in randomized controlled trials: a method to meet CONSORT guidelines.

Rees JR, Wade TJ, Levy DA, Colford JM Jr, Hilton JF.

Contemp Clin Trials. 2005 Feb;26(1):25-37. Epub 2005 Jan 27.

PMID:
15837450
5.
6.

Evaluating preference effects in partially unblinded, randomized clinical trials.

Halpern SD.

J Clin Epidemiol. 2003 Feb;56(2):109-15. Review.

PMID:
12654404
7.

Evidence-based medicine: four fundamental problems with the randomized clinical trial (RCT) used to document chemical medicine.

Ventegodt S, Andersen NJ, Brom B, Merrick J, Greydanus DE.

Int J Adolesc Med Health. 2009 Oct-Dec;21(4):485-96.

PMID:
20306761
8.

Reactions to treatment debriefing among the participants of a placebo controlled trial.

Di Blasi Z, Crawford F, Bradley C, Kleijnen J.

BMC Health Serv Res. 2005 Apr 22;5(1):30.

9.

Who controls the placebo? Introducing a Placebo Quality Checklist for pharmacological trials.

Brinkhaus B, Pach D, L├╝dtke R, Willich SN.

Contemp Clin Trials. 2008 Mar;29(2):149-56. Epub 2007 Jun 30.

PMID:
17669693
11.

Improving the quality of randomized controlled trials in Chinese herbal medicine, part II: control group design.

Bian ZX, Moher D, Dagenais S, Li YP, Liu L, Wu TX, Miao JX.

Zhong Xi Yi Jie He Xue Bao. 2006 Mar;4(2):130-6.

12.
13.

Effects of perceived treatment on quality of life and medical outcomes in a double-blind placebo surgery trial.

McRae C, Cherin E, Yamazaki TG, Diem G, Vo AH, Russell D, Ellgring JH, Fahn S, Greene P, Dillon S, Winfield H, Bjugstad KB, Freed CR.

Arch Gen Psychiatry. 2004 Apr;61(4):412-20. Erratum in: Arch Gen Psychiatry. 2004 Jun;61(6):627.

PMID:
15066900
14.

Patient motivation for participating in clinical trials for depression: validation of the motivation for clinical trials inventory-depression.

Andresen EL, Wilson KA, Castillo A, Koopman C.

Int Clin Psychopharmacol. 2010 Jan;25(1):7-16. doi: 10.1097/YIC.0b013e328332055c.

PMID:
19901843
15.

Double-blind versus deceptive administration of a placebo.

Kirsch I, Weixel LJ.

Behav Neurosci. 1988 Apr;102(2):319-23.

PMID:
3365327
16.

Influence of treatment preferences on validity: a review.

Sidani S, Miranda J, Epstein D, Fox M.

Can J Nurs Res. 2009 Dec;41(4):52-67. Review.

PMID:
20191713
17.

Cognitive performance following modafinil versus placebo in sleep-deprived emergency physicians: a double-blind randomized crossover study.

Gill M, Haerich P, Westcott K, Godenick KL, Tucker JA.

Acad Emerg Med. 2006 Feb;13(2):158-65. Epub 2006 Jan 25. Erratum in: Acad Emerg Med. 2006 Apr;13(4):477.

19.

In the dark: the reporting of blinding status in randomized controlled trials.

Montori VM, Bhandari M, Devereaux PJ, Manns BJ, Ghali WA, Guyatt GH.

J Clin Epidemiol. 2002 Aug;55(8):787-90.

PMID:
12384193

Supplemental Content

Support Center